Skip to main content

AbbVie’s latest disappointing trial data was probably worse than it looked

The company only included a percentage of patients in the trial in a Thursday data release.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.